Is Asthma Hereditary, Genetic, or Both?

Asthma is both hereditary and genetic, and the distinction between those two words matters more than most people realize. Twin studies estimate that genetic factors account for roughly 80 to 90 percent of the variation in who develops asthma, making it one of the most heritable common diseases.¹ But “genetic” and “hereditary” are not synonyms. Asthma involves hundreds of gene variants that individually nudge your risk by small amounts, and layered on top of that DNA blueprint are epigenetic changes shaped by your parents’ and even grandparents’ environments. Teasing those threads apart reveals why asthma clusters in families yet still surprises people who have no obvious family history.

How Strongly Asthma Runs in Families

Children of parents with asthma face a meaningfully higher chance of developing it themselves. One large review of the genetics literature describes the pattern plainly: asthma runs in families, and children of asthmatic parents are at increased risk.² Twin studies give a sharper picture. By comparing identical twins (who share all their DNA) with fraternal twins (who share about half), researchers can estimate how much of the disease is driven by genes versus environment. A Scandinavian study of adolescent twins found that the heritability of asthma rose from about 79 percent in 1994 to roughly 91 percent in 2003, a shift the authors attributed in part to environmental changes that may have amplified the expression of asthma-related genes.¹ That number does not mean 90 percent of asthma cases are caused solely by genes. It means that, within the studied population, about 90 percent of the variation in who does and does not get asthma can be traced to genetic differences rather than to differences in environment. The remaining fraction is attributed to non-shared environmental factors, things that differ between two siblings living in the same house.

Does It Matter Which Parent Has Asthma?

For decades, the prevailing clinical wisdom was that a mother’s asthma posed a bigger threat to her children than a father’s. A widely cited study found that maternal asthma carried an odds ratio of about 3.0 compared with roughly 2.4 for paternal asthma when all ages were pooled together.³ That gap was most pronounced in young children under five, where maternal asthma was associated with roughly five times the odds of a child having asthma while paternal asthma carried about 1.6 times the odds.⁴ In older children, both parents contributed similar risk.

Newer evidence has muddied this picture. A Danish population study of about 21,000 people found that paternal and maternal asthma conferred approximately equal risk to offspring, with odds ratios hovering between 2.5 and 3.0 for both parents. If anything, paternal allergy appeared to carry a marginally greater effect in some analyses.⁵ The takeaway for families is that having either parent with asthma substantially raises a child’s risk. The idea that maternal asthma is categorically worse may hold for very young children, but it oversimplifies the overall picture.

Hundreds of Genes, Not One

Asthma is not caused by a single gene the way cystic fibrosis or sickle cell disease is. It is polygenic, meaning many gene variants scattered across the genome each contribute a small amount to your overall susceptibility. Large-scale genome-wide association studies have now catalogued well over a hundred distinct chromosomal regions linked to asthma risk. A multi-ancestry analysis spanning more than 150,000 cases across 22 biobanks identified 179 genetic loci associated with asthma, of which 49 would have been missed if only European-ancestry populations had been studied.⁶ That last point is important: some risk variants are more common in certain populations, so a study that looks only at one group will miss part of the genetic landscape.

Among the most consistently replicated signals is the 17q12-21 locus on chromosome 17, which keeps showing up across studies of childhood asthma in different populations.⁷ Another well-established hotspot is the HLA region on chromosome 6, which is tied to immune function and has been strongly associated with IgE levels, the antibody central to allergic reactions. A study of Peruvian children confirmed a strong link between the HLA-DR/DQ region and total serum IgE, while also identifying a new lung-function locus on chromosome 19 that was replicated in Brazilian children with similar ancestry.⁸ These discoveries across diverse populations reinforce that the genetic architecture of asthma is broadly shared, even if specific variant frequencies differ.

Epigenetics and Why Your Parents’ Environment Matters

Here is where asthma genetics gets genuinely surprising. Your DNA sequence is only part of the story. Chemical tags, particularly methyl groups attached to DNA, can dial gene activity up or down without altering the underlying code. These epigenetic modifications can be influenced by everything from air pollution to diet to smoking, and some of these changes appear to be passed from parent to child.

A study of Latino children found that mothers who smoked during pregnancy had measurable changes in DNA methylation at a specific site on the AHRR gene in their children. That methylation change, in turn, was linked to higher odds of the child developing asthma. The researchers estimated that the indirect effect of maternal smoking funneled through this single epigenetic mark carried an odds ratio of about 1.18, accounting for a meaningful chunk of the total smoking-related asthma risk.⁹ Air pollution works through similar channels. In mouse experiments, combined exposure to diesel exhaust particles and allergens altered the methylation of asthma-related genes like IL4, with methylation levels tracking closely with changes in IgE, the allergic antibody.¹⁰

Even more remarkable is the evidence for transgenerational effects. In animal models, a single exposure to diesel exhaust particles during pregnancy created heightened asthma susceptibility that persisted into the second and, with lesser magnitude, third generation of offspring. The researchers traced this to altered DNA methylation in immune cells called dendritic cells, and the methylation changes carried across generations included genes involved in chromatin modification, hinting at cascading effects on gene regulation.¹¹ A broader review convened by the National Institute of Allergy and Infectious Diseases concluded that asthma risk can be transmitted across generations from a single environmental exposure, with epigenetic alterations in dendritic cells playing a mechanistic role.¹² The human evidence is still catching up to the animal data, but the implication is striking: your grandmother’s environmental exposures could have nudged your asthma risk in ways that have nothing to do with the DNA sequence she passed down.

When Genes and Environment Collide

One of the most studied gene-environment interactions in asthma involves growing up on a farm. Children raised around livestock and unpasteurized milk have lower rates of asthma and allergies, a finding that has held across many European studies. The genetic side of this equation involves immune-sensing genes, particularly those encoding toll-like receptors, which are proteins that detect microbial molecules. A large population-based study found that specific variants in the TLR6 gene interacted with childhood farm exposure to lower the risk of early-onset asthma. Children who carried certain TLR6 alleles and had grown up on farms saw a particularly strong protective effect.¹³

A systematic review of the CD14 gene, another microbial sensor, confirmed that most studies reported a significant interaction between CD14 variants and microbial exposure. The protective effect was seen primarily in children exposed early in life, not in adults.¹⁴ The timing matters: the same genetic variant can be protective or irrelevant depending on when in life the microbial exposure occurs. This helps explain why simply moving to a farm as an adult does not replicate the childhood protective effect. Your genes set a range of possible immune responses, but the environment during critical developmental windows determines where in that range you land.

Asthma Is Not One Disease

A major reason asthma genetics is complicated is that “asthma” is really an umbrella term covering several distinct subtypes. Allergic asthma, triggered by pollen, dust mites, or pet dander, has a different genetic signature than non-allergic asthma, which can be triggered by cold air, exercise, or infections. Research comparing atopic (allergic) and non-atopic asthma in children suggests genuine genetic heterogeneity between these subtypes.¹⁵ This means that a gene variant strongly linked to allergic asthma might have no effect at all on the non-allergic form. When large genetic studies lump all asthma together, they risk missing signals that are specific to certain subtypes and inflating signals that are really about allergy in general.

That inflation is real. A massive genome-wide analysis found 136 independent risk variants for allergic disease broadly defined as asthma, hay fever, or eczema. Strikingly, only six of those 136 variants were specific to one disease rather than shared across all three. Most of the genetic risk factors that drive asthma also drive hay fever and eczema, pointing to a common underlying tendency toward overactive immune responses rather than separate disease-specific pathways.¹⁶ If your family has a history of eczema or hay fever but not asthma specifically, that shared genetic architecture still raises your risk.

Your Genes Can Affect Which Medications Work

One of the most practically relevant branches of asthma genetics is pharmacogenomics, the study of how your DNA influences your response to medication. The three pillars of asthma treatment, inhaled corticosteroids, beta-agonist bronchodilators, and leukotriene modifiers, all show genetic variation in how well they work from person to person. Variants in the FCER2 gene have been linked to differences in exacerbation rates on inhaled corticosteroids. The ADRB2 gene, which encodes the beta-2 adrenergic receptor that bronchodilators target, has variants associated with differences in how much airways open in response to the drug. And for leukotriene modifiers, variants in genes like ALOX5, LTC4S, and ABCC1 contribute to variable drug responses.¹⁷

In practice, this means that the frustrating trial-and-error process many people go through with asthma medications has a partial genetic explanation. You are not imagining it if one inhaler seems to do nothing for you while working perfectly for someone else. A review of pharmacogenetic evidence confirmed that genetic variations in FCER2 affect corticosteroid response, variants in ABCC1 and LTC4S affect leukotriene modifier response, and ADRB2 variants affect beta-agonist response.¹⁸ The long-term vision is to use genetic testing to match patients with the right medication from the start, though routine clinical use of asthma pharmacogenomics is still limited.

Polygenic Risk Scores and Their Limits

With hundreds of known genetic variants each contributing small effects, researchers have tried to combine them into a single number, a polygenic risk score, that estimates an individual’s overall genetic susceptibility. A recent study evaluated a polygenic risk score built from asthma drug-response pathway genes and found it was associated with childhood asthma risk at high statistical significance. However, the score’s ability to discriminate between cases and controls was modest, with an area under the curve of about 0.63 for asthma risk and 0.64 for moderate-to-severe disease.¹⁹ To put that in perspective, a perfect predictor would score 1.0 and a coin flip would score 0.5, so 0.63 sits somewhere between informative and underwhelming for individual prediction.

Newer approaches are trying to boost accuracy by incorporating related traits alongside asthma itself. One method that pulls in endophenotypes, measurable biological traits linked to asthma like IgE levels and lung function, showed improved performance over standard polygenic scoring methods for childhood-onset asthma.²⁰ These scores are research tools at present, not something you would get at a checkup. But they illustrate how the genetics field is trying to move from listing risk variants toward actually predicting who will get sick.

Rare Single-Gene Disorders That Mimic Severe Asthma

While the vast majority of asthma is polygenic, a small number of people have severe asthma-like symptoms driven by mutations in a single gene. Loss-of-function variants in the filaggrin gene, which causes the skin condition ichthyosis vulgaris, are consistently associated with more severe asthma outcomes.²¹ Filaggrin is a structural protein in the skin barrier, and its absence allows allergens to penetrate more easily, priming the immune system for the kind of overreaction that drives both eczema and asthma.

A newly recognized category of conditions called Primary Atopic Disorders represents a subset of inborn immune errors characterized by severe allergy driven by genetic mutations that dysregulate type 2 immune responses. In these patients, severe eczema, asthma, food allergies, and eosinophilic gut disorders cluster together and often appear alongside other signs of immune dysfunction.²² These are rare, but they matter clinically because identifying a monogenic cause can change treatment entirely, pointing toward targeted immune therapies rather than standard inhalers.

The Gut Microbiome as a Genetic Modifier

An emerging frontier in asthma genetics is the interplay between your DNA and the microbes living in your gut. The connection is not as far-fetched as it sounds: gut bacteria train the immune system from infancy, and the composition of that bacterial community is itself partly shaped by host genetics.

A study of children found that certain gut bacteria appeared to have protective associations with asthma, but only in children who already carried a high genetic risk based on their polygenic risk score. Specifically, species like Ruminococcus bromii and Alistipes indistinctus were suggested to offer protective effects against asthma in genetically vulnerable children, while Bacteroides species interacted with host genetics to influence lung function.²³ In other words, the right gut bacteria might partially buffer genetic susceptibility.

Whether that association is causal remains an open question. A study of Hispanic and Latino adults in the United States identified gut taxa associated with asthma but found no evidence that these bacteria causally drove asthma risk when the researchers used genetic tools to test the direction of the relationship.²⁴ The bacteria might be responding to the same immune changes that drive asthma rather than preventing it. This is one of those areas where the science is genuinely unsettled, and anyone selling probiotic supplements as asthma prevention is getting ahead of the data.

Why Diverse Genetic Studies Matter

For years, asthma genetics research drew overwhelmingly from populations of European descent, which created real blind spots. The multi-ancestry biobank study mentioned earlier found that 49 of the 179 asthma-associated loci were missed in the European-only analysis. Thirteen of the newly discovered loci had index variants at higher frequencies in non-European populations.⁶ The reassuring finding was that these variants generally had consistent effects across populations. They are not population-specific genes that only matter in certain ethnic groups. They were simply harder to detect statistically in populations where they are less common.

This has practical implications for polygenic risk scores and eventually for precision medicine. A risk score calibrated on one population can perform poorly in another, not because the biology differs but because the variant frequencies do. As genetic databases grow more diverse, the tools built on them should become more equitable. For now, people of non-European ancestry should be aware that the genetic risk estimates they might encounter, whether from research studies or consumer genetic tests, were often built on data that underrepresents them, which limits their accuracy.